- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Dietary Supplement Action; AI in Healthcare; Border Crossings for Medicine
An FDA announcement that it would step up oversight of the $50-billion-a-year dietary supplements industry was met with mixed reaction; a group of researchers in the United States and China are testing artificial intelligence (AI) to automatically diagnose common childhood conditions after processing data; close to 1 million people in California alone cross the border to Mexico annually for healthcare, including to buy prescription drugs.
Reaction to FDA Dietary Supplement Move Mixed
An FDA announcement that it would step up oversight of the $50-billion-a-year dietary supplements industry was met with mixed reaction, The Washington Post reported. Some said the move is little more than a public relations effort, while others welcomed the effort to crack down on companies making false and misleading claims about health benefits or selling products adulterated with unlisted drug ingredients.
US, Chinese Researchers Working on AI Diagnostic System
A group of researchers in the United States and China are testing artificial intelligence (AI) to automatically diagnose common childhood conditions after processing the patient’s symptoms, history, lab results, and other clinical data, The New York Times reported. The AI system was highly accurate, according to findings. The report noted that the effort was aided by the fact that China’s privacy norms put fewer restrictions on the sharing of digital data drawn from a large Chinese population.
Californians Cross the Border to Mexico for Cheaper Prescription Drugs
Close to 1 million people in California alone cross the border to Mexico annually for healthcare, including to buy prescription drugs, Kaiser Health News reported. In Mexico, one type of insulin costs $600 for a 3-month supply compared with the $3700 price tag in the United States. The FDA largely looks the other way for people traveling and bringing medications back, as long as it is no more than a 90-day supply, but that could change at any time, experts said.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
